The British Medical Journal has published a call for regulation to ensure that clinical research carried out in Africa and other developing countries does not lead to the "taking advantage" of volunteers.
Sylvester Chima, a researcher in law at the Northumbria University, Newcastle-upon-Tyne, UK, said that "experimental medicine and biomedical research will always be hazardous but should always be encouraged within a framework of respect for autonomy, justice and human rights."
Among the regulations proposed by Mr Chima are guidance for: forming local research ethics committees; informed consent procedues; standards of care; and distributive justice (especially post-trial benefits and compensation for injuries). He added that he did not believe that such regulations would discourage clinical trials for pharmaceutical products in African countries.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze